Kevin McKernan

But the myocarditis story, I think why John's an interesting discussion on this is that he has the death records and he will tell you the myocarditis is the tip of the iceberg. There's way worse shit going on with seeing the myocarditis.

But the myocarditis story, I think why John's an interesting discussion on this is that he has the death records and he will tell you the myocarditis is the tip of the iceberg. There's way worse shit going on with seeing the myocarditis.

But the myocarditis story, I think why John's an interesting discussion on this is that he has the death records and he will tell you the myocarditis is the tip of the iceberg. There's way worse shit going on with seeing the myocarditis.

Yes. And Peter's been backing off of that now being like, they think they may have gotten a way to clear the spike protein now that they can explain. But before them having those treatment options, he was worried that that was the prognosis of someone with myocarditis prior to them finding a way of eliminating some of the spike protein.

Yes. And Peter's been backing off of that now being like, they think they may have gotten a way to clear the spike protein now that they can explain. But before them having those treatment options, he was worried that that was the prognosis of someone with myocarditis prior to them finding a way of eliminating some of the spike protein.

Yes. And Peter's been backing off of that now being like, they think they may have gotten a way to clear the spike protein now that they can explain. But before them having those treatment options, he was worried that that was the prognosis of someone with myocarditis prior to them finding a way of eliminating some of the spike protein.

But they are hopeful that that number is going to go down with the treatments that they've come across. I think you'll probably find a notice from the FDA about myocarditis. I don't know if they'll actually fit it on those tiny labels. Go to the FDA's website. Yeah.

But they are hopeful that that number is going to go down with the treatments that they've come across. I think you'll probably find a notice from the FDA about myocarditis. I don't know if they'll actually fit it on those tiny labels. Go to the FDA's website. Yeah.

But they are hopeful that that number is going to go down with the treatments that they've come across. I think you'll probably find a notice from the FDA about myocarditis. I don't know if they'll actually fit it on those tiny labels. Go to the FDA's website. Yeah.

Update on myocarditis.

Update on myocarditis.

Update on myocarditis.

This is the VRBAC committee. PDF.

This is the VRBAC committee. PDF.

This is the VRBAC committee. PDF.

I've spoken at one of these VRBAC meetings. I think this is probably... Okay, go up to that last one.

I've spoken at one of these VRBAC meetings. I think this is probably... Okay, go up to that last one.

I've spoken at one of these VRBAC meetings. I think this is probably... Okay, go up to that last one.

three uh three days and there's 250 reports this is confusing i don't know what this means yeah what you can see there is a dose response i mean that's what you'll see in so in jessica's paper and what jessica and peter did is they put this through uh what's known as a bradford hill criteria so if you want to try and derive causation from you know from correlative information because

three uh three days and there's 250 reports this is confusing i don't know what this means yeah what you can see there is a dose response i mean that's what you'll see in so in jessica's paper and what jessica and peter did is they put this through uh what's known as a bradford hill criteria so if you want to try and derive causation from you know from correlative information because